hims semaglutide dosage A new era of weight management is coming to & Hers. In partnership with Novo Nordisk, Hims & Hers will soon offer access to the only FDA-approved GLP-1 weight loss pill Ozempic® | Hims

PSG estimates that over 5% of the Medicare Part D population is already taking a GLP-1 for diabetes in 2024, and this number could easily double in the coming years

GLP-1 agonists mimic this hormone, which improves blood sugar levels, slows the movement of food from the stomach into the small intestine during digestion, and helps people feel satiated

Youve probably heard it before: just get a B12 shot and the weight will start coming off

Keep a simple tracking sheet or use a smartphone app to record injection dates and locationsthis removes guesswork and ensures you never inject the same spot too frequently

Clients who have a history of the following SHOULD NOT take Semaglutide:: Type I diabetes A history of pancreatitis (inflammation of the pancreas) Active suicidal thoughts A history of allergic reaction to any of the components of semaglutide A personal or family history of medullary thyroid carcinoma A personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN2) Patients who are currently pregnant, may become pregnant, or breastfeeding